Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 7/20 | 1.00 |
| ▸ | MIF | P14174 | 1/20 | 0.51 |
| ▸ | PHOSPHO1 | Q8TCT1 | 3/20 | 0.43 |
| ▸ | G6PD | P11413 | 1/20 | 0.43 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7623894 | 0.79 | KAT2B (0.67) | KAT2BMIFG6PDMAPTALDH1A1 | |
| SCHEMBL11193393 | 0.75 | KAT2B (0.60) | KAT2BPHOSPHO1G6PDTLR9MAPT | |
| SCHEMBL2108805 | 0.73 | KAT2B (0.73) | KAT2BPHOSPHO1MAPTMEN1KMT2A | |
| SCHEMBL81082 | 0.71 | KAT2B (0.59) | KAT2BMAPTALDH1A1SCN2APKM | |
| SCHEMBL1896800 | 0.66 | PHOSPHO1 (0.70) | KAT2BMIFPHOSPHO1G6PDTLR9 | |
| SCHEMBL9187712 | 0.65 | GSK3A (0.56) | KAT2BMAPTALDH1A1SCN2AGSK3A | |
| SCHEMBL27909482 | 0.65 | ALDH1A1 (0.72) | ALDH1A1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL22567 | 0.65 | ALDH1A1 (0.72) | ALDH1A1HSD17B10MEN1KMT2ALMNA | |
| SCHEMBL23878375 | 0.65 | MAPT (0.51) | KAT2BMAPTALDH1A1SCN2AHSD17B10 | |
| SCHEMBL9320105 | 0.65 | KAT2B (0.47) | KAT2BMAPTALDH1A1SCN2AGSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605407-B2 | Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-04-21 | — | — | US | claimed |
| US-20250075176-A1 | COMPOSITIONS COMPRISING HISTONE ACETYLTRANSFERASE INHIBITORS OR REVERSE TRANSCRIPTASE INHIBITORS AND USE THEREOF | FOREVE LABS LTD. (IL) | 2025-03-06 | — | — | US | claimed |
| CN-119343442-A | Compositions comprising histone acetyltransferase inhibitors or reverse transcriptase inhibitors and uses thereof | 永恒实验室公司 | 2025-01-21 | — | — | CN | claimed |
| EP-4490269-A1 | COMPOSITIONS COMPRISING HISTONE ACETYLTRANSFERASE INHIBITORS OR REVERSE TRANSCRIPTASE INHIBITORS AND USE THEREOF | Foreve Labs Ltd. (IL) | 2025-01-15 | — | — | EP | claimed |
| WO-2023170667-A1 | COMPOSITIONS COMPRISING HISTONE ACETYLTRANSFERASE INHIBITORS OR REVERSE TRANSCRIPTASE INHIBITORS AND USE THEREOF | FOREVE LABS LTD. (IL) | 2023-09-14 | — | — | WO | claimed |
| EP-3813852-A1 | METHODS TO INDUCE TERMINAL DIFFERENTIATION IN STEM CELLS BY INTERFERING WITH DNA REPLICATION, METHODS OF INDUCING PANCREATIC DIFFERENTIATION, AND DIFFERENTIATED CELLS OBTAINED THEREOF | The Trustees of Columbia University in the City of New York (US) | 2021-05-05 | — | — | EP | claimed |
| US-20210052665-A1 | METHODS TO INDUCE TERMINAL DIFFERENTIATION IN STEM CELLS BY INTERFERING WITH DNA REPLICATION, METHODS OF INDUCING PANCREATIC DIFFERENTIATION, AND DIFFERENTIATED CELLS OBTAINED THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2021-02-25 | — | — | US | claimed |
| US-20090027774-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-01-29 | — | — | US | claimed |
| EP-1860469-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-11-28 | — | — | EP | claimed |
| EP-4748838-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12630527-B2 | Broad spectrum anti-cancer compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-19 | — | — | US | disclosed |
| US-12605407-B2 | Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4045498-B1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | UNIV CALIFORNIA (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4652455-A2 | METHODS FOR ANALYSIS OF CELL-FREE NUCLEIC ACIDS IN URINE | Grail, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20110177315-A1 | DICHROIC DYE COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, AND POLARIZING ELEMENT | FUJIFILM CORPORATION (JP) | 2011-07-21 | — | — | US | disclosed |
| WO-2011030883-A1 | COLOR FILTER AND LIGHT-EMITTING DISPLAY ELEMENT | FUJIFILM CORPORATION (JP) | 2011-03-17 | — | — | WO | disclosed |
| US-20100134726-A1 | POLARIZING ELEMENT AND METHOD OF PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20090027774-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1860469-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630527-B2 | Broad spectrum anti-cancer compounds | YTHDF3, YTHDF1, YTHDF2 | KAT2B 2423/4885MIF 1365/4885PHOSPHO1 2978/4885 |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | C1S, CDY1; CDY1B, CRY1 | KAT2B 1623/4885MIF 4449/4885PHOSPHO1 2066/4885 |
| US-12605407-B2 | Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof | CCND1, CCNB3, MKI67 | KAT2B 2199/4885MIF 3927/4885PHOSPHO1 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.